Myalgia
Welcome,         Profile    Billing    Logout  
 18 Companies   19 Products   19 Products   0 Mechanisms of Action   0 Trials   115 News 


12»
  • ||||||||||  Trial completion, Trial completion date:  Phase II Study of AP0302 5% Versus a Vehicle Comparator (clinicaltrials.gov) -  Feb 25, 2019   
    P2,  N=147, Completed, 
    Recruiting --> Completed | Trial completion date: Jul 2015 --> Jun 2016
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Benefit of CoQ-10 in Patients on Statins (clinicaltrials.gov) -  May 3, 2016   
    P=N/A,  N=37, Completed, 
    Not yet recruiting --> Suspended | Trial primary completion date: Dec 2015 --> Dec 2017 Recruiting --> Completed | N=68 --> 37 | Trial primary completion date: Feb 2012 --> Jul 2014
  • ||||||||||  Rituxan (rituximab) / Roche
    Enrollment change, Trial termination, Trial primary completion date:  B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome (clinicaltrials.gov) -  Apr 12, 2016   
    P2,  N=8, Terminated, 
    Recruiting --> Completed | N=68 --> 37 | Trial primary completion date: Feb 2012 --> Jul 2014 N=10 --> 8 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Apr 2016; Difficulties in logistics handling the very severe patients (travel, hospital stay, follow-up)
  • ||||||||||  Trial completion, Phase classification:  Effect of American Ginseng on Exercise-induced Muscle Soreness (clinicaltrials.gov) -  Mar 4, 2016   
    P1,  N=10, Completed, 
    N=10 --> 8 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Apr 2016; Difficulties in logistics handling the very severe patients (travel, hospital stay, follow-up) Available --> Completed | Phase classification: PN/A --> P1
  • ||||||||||  Trial completion, Enrollment change:  Neurotropin Treatment of Fibromyalgia (clinicaltrials.gov) -  Dec 10, 2015   
    P2,  N=55, Completed, 
    Available --> Completed | Phase classification: PN/A --> P1 Recruiting --> Completed | N=78 --> 55
  • ||||||||||  Enbrel (etanercept) / Pfizer, Amgen, Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
    Trial primary completion date:  Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome (clinicaltrials.gov) -  Dec 4, 2015   
    P2,  N=4, Terminated, 
    Recruiting --> Active, not recruiting Trial primary completion date: Apr 2015 --> Aug 2014
  • ||||||||||  Enrollment closed, Trial primary completion date:  Efficacy of Microcurrent Therapy After Eccentric Exercise (clinicaltrials.gov) -  May 27, 2015   
    P=N/A,  N=15, Active, not recruiting, 
    Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> May 2015
  • ||||||||||  Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date:  CFS:M: Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder (clinicaltrials.gov) -  Apr 13, 2015   
    P2,  N=0, Withdrawn, 
    Initiation date: Sep 2014 --> Aug 2015 | Trial primary completion date: Dec 2014 --> Dec 2015 N=24 --> 0 | Initiation date: Sep 2012 --> Mar 2012 | Not yet recruiting --> Withdrawn | Trial primary completion date: Sep 2014 --> Feb 2013
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise (clinicaltrials.gov) -  Apr 8, 2015   
    P4,  N=69, Completed, 
    N=24 --> 0 | Initiation date: Sep 2012 --> Mar 2012 | Not yet recruiting --> Withdrawn | Trial primary completion date: Sep 2014 --> Feb 2013 Recruiting --> Completed | N=26 --> 69 | Trial primary completion date: Dec 2014 --> Sep 2014
  • ||||||||||  Enrollment change, Trial withdrawal, Trial primary completion date:  Vitamin D Replacement in Statin-Induced Myopathy (clinicaltrials.gov) -  Apr 7, 2015   
    P=N/A,  N=0, Withdrawn, 
    Recruiting --> Completed | N=26 --> 69 | Trial primary completion date: Dec 2014 --> Sep 2014 N=120 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Oct 2012 --> Jul 2012
  • ||||||||||  Caldolor (ibuprofen) / Grifols, Cumberland
    Trial primary completion date:  IV Ibuprofen for Post-Electroconvulsive Therapy Myalgia (clinicaltrials.gov) -  Mar 11, 2015   
    P4,  N=14, Terminated, 
    N=120 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Oct 2012 --> Jul 2012 Trial primary completion date: Dec 2014 --> Sep 2014
  • ||||||||||  Trial primary completion date:  Neurotropin Treatment of Fibromyalgia (clinicaltrials.gov) -  Mar 5, 2015   
    P2,  N=78, Recruiting, 
    Trial primary completion date: Dec 2014 --> Sep 2014 Trial primary completion date: Feb 2015 --> Dec 2015
  • ||||||||||  Trial primary completion date:  Neurotropin Treatment of Fibromyalgia (clinicaltrials.gov) -  Feb 27, 2015   
    P2,  N=78, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Feb 2015
  • ||||||||||  Jesduvroq (daprodustat) / GSK, Kyowa Kirin
    Enrollment open:  GSK1278863 Effects on Eccentric Exercise-Induced Muscle Damage (clinicaltrials.gov) -  Feb 23, 2015   
    P1,  N=30, Recruiting, 
    Trial primary completion date: Dec 2015 --> Feb 2015 Not yet recruiting --> Recruiting
  • ||||||||||  Trial completion:  Psychological Wellbeing in Chronic Fatigue Syndrome (clinicaltrials.gov) -  Jan 15, 2015   
    P=N/A,  N=61, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed
  • ||||||||||  Trial primary completion date:  Neurotropin Treatment of Fibromyalgia (clinicaltrials.gov) -  Jan 2, 2015   
    P2,  N=78, Recruiting, 
    Recruiting --> Completed | N=230 --> 119 | Trial primary completion date: Aug 2014 --> Jan 2015 Trial primary completion date: Dec 2014 --> Dec 2015
  • ||||||||||  Caldolor (ibuprofen) / Grifols, Cumberland
    Enrollment change, Trial termination:  IV Ibuprofen for Post-Electroconvulsive Therapy Myalgia (clinicaltrials.gov) -  Sep 28, 2014   
    P4,  N=14, Terminated, 
    Trial primary completion date: Feb 2014 --> Oct 2015 N=40 --> 14 | Recruiting --> Terminated; unable to increase to target enrollment
  • ||||||||||  Enbrel (etanercept) / Pfizer, Amgen, Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
    Enrollment change, Trial termination:  Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome (clinicaltrials.gov) -  Sep 4, 2014   
    P2,  N=4, Terminated, 
    Trial primary completion date: Dec 2013 --> Dec 2015 N=15 --> 4 | Recruiting --> Terminated; After inclusion of four patients, two experienced moderate worsening of symptoms
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Maintenance of Muscle Mass in Older People: the Negative Impact of Statin Therapy (clinicaltrials.gov) -  Sep 4, 2014   
    P=N/A,  N=18, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=30 --> 18 | Trial primary completion date: Dec 2012 --> Mar 2011
  • ||||||||||  Enrollment open:  Psychological Wellbeing in Chronic Fatigue Syndrome (clinicaltrials.gov) -  Aug 12, 2014   
    P=N/A,  N=60, Recruiting, 
    Enrolling by invitation --> Completed Not yet recruiting --> Recruiting